Prevantics Swab Drug Recall for Test Method Validation Deficiency
Professional Disposables International, Inc. is recalling Prevantics Swab (chlorhexidine gluconate and isopropyl alcohol) due to cGMP deviations involving inadequate validation of manufacturing test methods. The product was distributed nationwide in the USA and Puerto Rico.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall involving cGMP deviations related to test method validation—a manufacturing process deficiency rather than a direct safety hazard with reported illness or injury. The source text does not report any illnesses, injuries, or confirmed product failures, making this a precautionary recall grounded in manufacturing compliance concerns.
Plain-English summary
Professional Disposables International, Inc. is recalling Prevantics Swab, which contains chlorhexidine gluconate (3.15% w/v) and isopropyl alcohol (70% v/v). The recall affects two packaged configurations: individual 1 mL swabs in pouches (100 per carton or 3000 per case), distributed with specific lot numbers and expiration dates ranging from February 2022 through May 2023.
The recall was initiated due to current Good Manufacturing Practice (cGMP) deviations. Specifically, the FDA determined there was uncertainty regarding the adequacy of validation of the test methods used to manufacture the products.
The affected product was distributed nationwide in the United States and Puerto Rico. A total of 160,531 cases of the 100-swab configuration and 16,123 cases of the 3,000-swab configuration are subject to this recall.
Consumers and healthcare facilities in possession of affected lots should stop using the product and contact Professional Disposables International, Inc. for instructions on return or disposal.
The recalled product
- Product
- PREVANTICS SWAB (CHLORHEXIDINE GLUCONATE AND ISOPROPYL ALCOHOL)
- Brand
- PREVANTICS SWAB
- Manufacturer
- Professional Disposables International, Inc.
- Category
- Drug — Topical Antiseptic
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Lot #: a) 12000165
- 12000166
- 12000382
- Exp Feb 2022
- 12000228
- 12000381
- 12000383
- 12000577
- 12000578
- 12000579
- 12000661
- 12000662
- Exp Mar 2022
- 12000659
- 12000660
- Exp Apr 2022
- 12001060
- 12001061
- 12001062
- 12001100 LE
Distribution
Part of a larger recall action
This product is one of 3 recalled by Professional Disposables International, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 3 products in this recall →Related recalls
Same manufacturer · Professional Disposables International, Inc.
See all →- ModeratePrevantics Maxi Swabstick Recall Due to Manufacturing Validation Issues
FDA (Drugs) · 2022-03-02
- ModeratePrevantics Swabstick Chlorhexidine Recall Due to Test Validation Uncertainty
FDA (Drugs) · 2022-03-02
- ModeratePVP Iodine Prep Pads Recalled for Subpotent Active Ingredient
FDA (Drugs) · 2021-09-01
- ModeratePDI Povidone-Iodine Prep Pads Recalled for Subpotent Active Ingredient
FDA (Drugs) · 2021-09-01
- ModeratePDI Povidone-Iodide Cleansing Scrub Swabstick Recall for Subpotency
FDA (Drugs) · 2021-09-01
Same hazard · cGMP deviation
See all →- HighCinacalcet Tablets Recalled for N-Nitroso Impurity Exceeding Limits
FDA (Drugs) · 2026-07-08
- SevereCinacalcet Tablets Recalled for cGMP Deviations
FDA (Drugs) · 2026-07-08
- ModerateFentanyl Citrate Injectable Solution Recalled for cGMP Deviations
FDA (Drugs) · 2026-05-06
- ModerateIndomethacin Extended-Release Capsules recalled for cGMP deviations
FDA (Drugs) · 2025-06-11
- SevereLubricant Eye Drops Solution recalled due to sterility assurance concerns
FDA (Drugs) · 2025-05-14